We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
Please access the following link for more details http://www.bmj.com/content/350/bmj.h3044/rr-0 The local FOB test There is no other clinical use for this
with rapidly evolving severe (RES) multiple sclerosis For second- and third-line therapy (includes all patients with highly active relapsing remitting (RR